These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9735408)

  • 1. Efficacious diagnosis of primary and metastatic human carcinomas with a combination of p53 mutation analysis and clonality analysis of androgen receptor gene.
    Aotake T; Muraoka R; Matsukawa S; Tanigawa N
    Int J Oncol; 1998 Oct; 13(4):773-9. PubMed ID: 9735408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas.
    Noguchi M; Maezawa N; Nakanishi Y; Matsuno Y; Shimosato Y; Hirohashi S
    Diagn Mol Pathol; 1993 Mar; 2(1):29-35. PubMed ID: 8287223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
    Bao L; Messer K; Schwab R; Harismendy O; Pu M; Crain B; Yost S; Frazer KA; Rana B; Hasteh F; Wallace A; Parker BA
    PLoS One; 2015; 10(11):e0142487. PubMed ID: 26554380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous and metachronous lung carcinomas: molecular evidence for multicentricity.
    Hiroshima K; Toyozaki T; Kohno H; Ohwada H; Fujisawa T
    Pathol Int; 1998 Nov; 48(11):869-76. PubMed ID: 9832055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
    Chang YL; Wu CT; Lin SC; Hsiao CF; Jou YS; Lee YC
    Clin Cancer Res; 2007 Jan; 13(1):52-8. PubMed ID: 17200338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
    Fukuda M; Nakatsuka T; Kusama K; Sakashita H
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the p53 gene mutations in patients with multiple primary cancers of the oesophagus.
    Mayama T; Mori T; Abe K; Sasano H; Nishihira T; Satomi S; Horii A
    Eur J Surg Oncol; 1997 Aug; 23(4):298-303. PubMed ID: 9315056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
    Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
    Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
    Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
    Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the molecular relationship between multiple tumors within one patient is of clinical importance.
    van der Sijp JR; van Meerbeeck JP; Maat AP; Zondervan PE; Sleddens HF; van Geel AN; Eggermont AM; Dinjens WN
    J Clin Oncol; 2002 Feb; 20(4):1105-14. PubMed ID: 11844836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [p53 gene abnormalities in advanced primary lung cancer and metastatic tumors].
    Taniguchi Y
    Nihon Ika Daigaku Zasshi; 1995 Jun; 62(3):241-50. PubMed ID: 7615696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis.
    Shimizu S; Yatabe Y; Koshikawa T; Haruki N; Hatooka S; Shinoda M; Suyama M; Ogawa M; Hamajima N; Ueda R; Takahashi T; Mitsudomi T
    Clin Cancer Res; 2000 Oct; 6(10):3994-9. PubMed ID: 11051248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers.
    Mitsudomi T; Yatabe Y; Koshikawa T; Hatooka S; Shinoda M; Suyama M; Sugiura T; Ogawa M; Takahashi T
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):354-60. PubMed ID: 9305187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
    Esrig D; Spruck CH; Nichols PW; Chaiwun B; Steven K; Groshen S; Chen SC; Skinner DG; Jones PA; Cote RJ
    Am J Pathol; 1993 Nov; 143(5):1389-97. PubMed ID: 7901994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.
    Soong R; Iacopetta BJ
    Mod Pathol; 1997 Mar; 10(3):252-8. PubMed ID: 9071734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
    Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
    Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer.
    Fujita M; Enomoto T; Wada H; Inoue M; Okudaira Y; Shroyer KR
    Am J Clin Pathol; 1996 Mar; 105(3):350-9. PubMed ID: 8602617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.